Medpace Q1 2021 Earnings Report
Key Takeaways
Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2021. Revenue increased by 12.6% to $260.0 million compared to the prior-year period. Net new business awards were $356.2 million, and GAAP net income was $43.3 million, or $1.14 per diluted share.
Revenue for the first quarter of 2021 increased 12.6% to $260.0 million.
Net new business awards were $356.2 million in the first quarter of 2021, representing an increase of 44.2% from the comparable prior-year period.
First quarter of 2021 GAAP net income was $43.3 million, or $1.14 per diluted share.
EBITDA was $53.6 million for the first quarter of 2021, an increase of 32.1% from the comparable prior-year period.
Medpace
Medpace
Forward Guidance
The Company forecasts 2021 revenue in the range of $1.090 billion to $1.150 billion. GAAP net income for full year 2021 is forecasted in the range of $160.6 million to $167.6 million. Additionally, full year 2021 EBITDA is expected in the range of $205.0 million to $215.0 million.